|
|
.
See Category: Congenital malformations, deformations and chromosomal abnormalities
ICD-10 (CM) Code and Descriptor
|
Q27.8 |
Other specified congenital malformations of peripheral vascular system
|
Q278 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 18.66%
|
20.89%
|
16.58%
|
11.87%
|
8.16%
|
5.57%
|
4.17%
|
2.91%
|
2.37%
|
1.55%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Q27.8*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
142
|
11,810
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
110
|
110
|
|
J3010
|
FENTANYL CITRATE INJECTION |
66
|
123
|
|
71275
|
CT ANGIOGRAPHY CHEST |
66
|
66
|
|
82565
|
ASSAY OF CREATININE |
65
|
65
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
64
|
2,054
|
|
J2405
|
ONDANSETRON HCL INJECTION |
62
|
320
|
|
97110
|
THERAPEUTIC EXERCISES |
57
|
102
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
55
|
398
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
54
|
54
|
|
97112
|
NEUROMUSCULAR REEDUCATION |
41
|
70
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
40
|
96
|
|
85610
|
PROTHROMBIN TIME |
40
|
40
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
36
|
61
|
|
97116
|
GAIT TRAINING THERAPY |
35
|
42
|
|
G1004
|
CDSM NDSC |
35
|
43
|
|
37241
|
VASC EMBOLIZE/OCCLUDE VENOUS |
35
|
36
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
33
|
149
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
30
|
116
|
|
80048
|
METABOLIC PANEL TOTAL CA |
29
|
29
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Q27.8 related to the following DRG Codes:
299-301
|
